Published online Mar 31, 2007.
https://doi.org/10.4111/kju.2007.48.3.348
Male Patients with the Diagnoses of Synchronous Prostate and Breast Cancer
Abstract
Prostate cancer and male breast cancer are similar in many ways, including the potential role of steroidal hormones in their pathogenesis and shared genetic abnormalities. However, the combination of these cancers in the same patient is rare. Herein, the case of a male patient, diagnosed with synchronous prostate and breast cancers, is reported.
Fig. 1
(A) The tumor cell nests forming a solid mass, with pushing margin infiltrates into normal breast parenchyma (H&E, ×100). (B) The tumor cells are large, with prominent nucleoli (H&E, ×400).
Fig. 2
Immunohistochemical staining for the prostate-specific antigen (PSA) (A) and prostate associated protein antigen (PAP) (B) showing negative reactions in a breast ductal carcinoma.
Fig. 3
(A) The small compact tumor cell nests infiltrating into the normal prostatic parenchyma (H&E, ×200). (B) The tumor cells have prominent basophilic nucleoli, which are characteristic of a prostatic adenocarcinoma (H&E, ×400).
Fig. 4
Immunohistochemical staining for the prostate-specific antigen (PSA) (A) and prostate associated protein antigen (PAP) (B) showing positive reactions.
Table 1
Treatment of patients with male breast cancer and prostate cancer
References
-
Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst 1999;91:1310–1316.
-